<?xml version="1.1" encoding="utf-8"?>
<article xsi:noNamespaceSchemaLocation="http://jats.nlm.nih.gov/publishing/1.1/xsd/JATS-journalpublishing1-mathml3.xsd" dtd-version="1.1" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><front><journal-meta><journal-id journal-id-type="publisher-id">JCNR</journal-id><journal-title-group><journal-title>Journal of Clinical and Nursing Research</journal-title></journal-title-group><issn>2208-3685</issn><eissn>2208-3693</eissn><publisher><publisher-name>Bio-Byword Scientific Publishing Pty. Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.26689/jcnr.v9i6.10963</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title>A Study of Staged Differences in the Needs of Lymphoma Patients throughout the Service under the Care Perspective</title><url>https://artdesignp.com/journal/JCNR/9/6/10.26689/jcnr.v9i6.10963</url><author>QianYaru,HuDeying</author><pub-date pub-type="publication-year"><year>2025</year></pub-date><volume>9</volume><issue>6</issue><history><date date-type="pub"><published-time>2025-07-03</published-time></date></history><abstract>Based on the perspective of caring, this study constructs a whole-cycle management programme for lymphoma patients, and systematically explores the pathway of patients’ health management from diagnosis to recovery by integrating literature analysis, clinical practice research, and multidisciplinary experts’ consensus. Focusing on the differentiated needs of patients, the study proposes a dual-track management framework of ‘precise diagnosis and treatment standard’ and ‘humanistic care practice’, and innovatively designs a multidisciplinary collaborative mechanism, an information-based follow-up platform, and a social support network. Through the role of ‘care consultant’, the programme connects the medical team with the individual needs of patients, strengthens treatment compliance and improves the quality of life, and provides a theoretical basis and practical reference for the optimization of the whole management mode of lymphoma patients.</abstract><keywords/></article-meta></front><body/><back><ref-list><ref id="B1" content-type="article"><label>1</label><element-citation publication-type="journal"><p>Chinese Society of Clinical Oncology (CSCO), Chinese Anti-Lymphoma Alliance, Guidelines Working Committee of the Chinese Society of Clinical Oncology, 2023, CSCO Lymphoma Diagnosis and Treatment Guidelines (2023 edition). People’s Health Publishing House, China.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B2" content-type="article"><label>2</label><element-citation publication-type="journal"><p>Chinese Society of Clinical Oncology (CSCO), Chinese Anti-Lymphoma Alliance, Chinese Medical Association, Hematology Branch, 2021, Expert Consensus on the Management Model for Chinese Lymphoma Patients throughout the Course (2021 edition). Chinese Journal of Hematology, 42(5): 5.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B3" content-type="article"><label>3</label><element-citation publication-type="journal"><p>Cao W, Chen HD, Yu YW, et al., 2021, Changing Profiles of Cancer Burden Worldwide and in China: A Secondary Analysis of the Global Cancer Statistics 2020. Chinese Medical Journal, 134(7): 783–791.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B4" content-type="article"><label>4</label><element-citation publication-type="journal"><p>Terpos E, Mikhael J, Hajek R, et al., 2021, Management of Patients with Multiple Myeloma Beyond the Clinical-Trial Setting: Understanding the Balance Between Efficacy, Safety and Tolerability, and Quality of Life. Blood Cancer Journal, 11(2): 40.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B5" content-type="article"><label>5</label><element-citation publication-type="journal"><p>Brown K, Richardson J, 2021, Psychological Intervention in Lymphoma Patients: Effects on Anxiety, Depression, and Quality of Life. British Journal of Haematology, 192(3): 512–521.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B6" content-type="article"><label>6</label><element-citation publication-type="journal"><p>Tan KP, Talaulikar D, Scholz B, 2023, Factors of Emotional Distress in Lymphoma: A Systematic Review. Cancer Medicine, 12(13): 14646–14662.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B7" content-type="article"><label>7</label><element-citation publication-type="journal"><p>Berkley A, 2022, Support for Adult Survivors of Lymphoma: A Literature Review. British Journal of Nursing, 31(17): S12–S16.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B8" content-type="article"><label>8</label><element-citation publication-type="journal"><p>Global Cancer Observatory, 2018, Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer Journal for Clinicians, 68: 394–424.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B9" content-type="article"><label>9</label><element-citation publication-type="journal"><p>Allemani C, et al., 2018, Global Surveillance of Trends in Cancer Survival 2000–14 (CONCORD-3): Analysis of Individual Records for 37,513,025 Patients Diagnosed with One of 18 Cancers from 322 Population-Based Registries in 71 Countries. The Lancet, 391(10125): 1023–1075.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B10" content-type="article"><label>10</label><element-citation publication-type="journal"><p>MacNeil Vroomen J, et al., 2015, Community-Dwelling Patients with Dementia and Their Informal Caregivers with and without Case Management: 2-Year Outcomes of a Pragmatic Trial. Journal of the American Medical Directors Association, 16(9): 800.1–800.8.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B11" content-type="article"><label>11</label><element-citation publication-type="journal"><p>Brufsky AM, 2017, Long-Term Management of Patients with Hormone Receptor-Positive Metastatic Breast Cancer: Concepts for Sequential and Combination Endocrine-Based Therapies. Cancer Treatment Reviews, 57: 16–25.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B12" content-type="article"><label>12</label><element-citation publication-type="journal"><p>Davis A, Patel K, et al., 2023, Wearable Technology for Continuous Health Monitoring in Lymphoma Patients: A Prospective Clinical Trial. Blood Advances, 7(12): 2501–2510.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B13" content-type="article"><label>13</label><element-citation publication-type="journal"><p>Islam MS, 2018, Treat Patient, Not Just the Disease: Holistic Needs Assessment for Haematological Cancer Patients. Oncology Reviews, 12(2): 374.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B14" content-type="article"><label>14</label><element-citation publication-type="journal"><p>Garcia M, Martinez L, 2022, Personalized Nutrition and Immune Support in Lymphoma Patients: A Precision Medicine Approach. Haematologica, 107(8): 1856–1868.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B15" content-type="article"><label>15</label><element-citation publication-type="journal"><p>Miller C, Taylor S, 2020, Family Involvement in Lymphoma Patient Care: Enhancing Adherence and Psychological Well-Being. Cancer Nursing, 43(2): 97–105.</p><pub-id pub-id-type="doi"/></element-citation></ref></ref-list></back></article>
